Works matching IS 1619-7070 AND VI 49 AND IP 10 AND DT 2022

Results: 34

To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3316, doi. 10.1007/s00259-022-05841-6

By:

Tuncel, Murat;
Vrachimis, Alexis;
Campenni, Alfredo;
de Keizer, Bart;
Verburg, Frederik A.;
Kreissl, Michael C.;
Ovcaricek, Petra Petranovic;
Geliashvili, Tamara;
Giovanella, Luca

Publication type:

Article

Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3598, doi. 10.1007/s00259-022-05855-0

By:

Wallis, David;
Soussan, Michaël;
Lacroix, Maxime;
Akl, Pia;
Duboucher, Clément;
Buvat, Irène

Publication type:

Article

Letter to the editor.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3334, doi. 10.1007/s00259-022-05850-5

By:

Zogala, David;
Ptáčník, Václav;
Maříková, Irena;
Chroustová, Daniela;
Šámal, Martin

Publication type:

Article

EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA).

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3328, doi. 10.1007/s00259-022-05864-z

By:

Fanti, Stefano;
Kunikowska, Jolanta;
Walz, Jochen;
Witjes, Wim;
Bjartell, Anders

Publication type:

Article

[177Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3332, doi. 10.1007/s00259-022-05833-6

By:

Vigne, Jonathan;
Chrétien, Basile;
Bignon, Anne-Laure;
Bouhier-Leporrier, Karine;
Dolladille, Charles

Publication type:

Article

Response to letter to the editor.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3336, doi. 10.1007/s00259-022-05900-y

By:

Kersting, David;
Sraieb, Miriam;
Fendler, Wolfgang Peter;
Büther, Florian;
Rischpler, Christoph

Publication type:

Article

2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3309, doi. 10.1007/s00259-022-05881-y

By:

Graham, Richard;
Moreira, Ana P.;
Glaudemans, Andor W. J. M.;
Jensen, Lars Thorbjørn;
Mihaïlovic, Jasna;
Nazarenko, Sergei;
Ozcan, Zehra;
Piciu, Doina;
Wadsak, Wolfgang;
Kunikowska, Jolanta;
Jamar, François

Publication type:

Article

Hossein Jadvar and Patrick M. Colletti (Eds): Nuclear Medicine: the Essentials: Lippincott Williams & Wilkins (LWW) 2021. ISBN: 978–1-49–630,064-5.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3305, doi. 10.1007/s00259-022-05875-w

By:

Mansi, Luigi

Publication type:

Article

Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3306, doi. 10.1007/s00259-022-05829-2

By:

Chiti, Lavinia Elena;
Nolff, M. C.;
Stefanello, D.

Publication type:

Article

225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3596, doi. 10.1007/s00259-022-05826-5

By:

Peng, Dengsai;
Liu, Hanxiang;
Huang, Ling;
Cao, Jianpeng;
Chen, Yue

Publication type:

Article

The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3470, doi. 10.1007/s00259-022-05820-x

By:

Cao, Jingjia;
Zhu, Xiaolu;
Sun, Yaru;
Li, Xiao;
Yun, Canhua;
Zhang, Wei

Publication type:

Article

Quantification of amyloid PET for future clinical use: a state-of-the-art review.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3508, doi. 10.1007/s00259-022-05784-y

By:

Pemberton, Hugh G.;
Collij, Lyduine E.;
Heeman, Fiona;
Bollack, Ariane;
Shekari, Mahnaz;
Salvadó, Gemma;
Alves, Isadora Lopes;
Garcia, David Vallez;
Battle, Mark;
Buckley, Christopher;
Stephens, Andrew W.;
Bullich, Santiago;
Garibotto, Valentina;
Barkhof, Frederik;
Gispert, Juan Domingo;
Farrar, Gill

Publication type:

Article

Construction and implementation of regional high-level PET alliance based on international consensus.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3330, doi. 10.1007/s00259-022-05796-8

By:

Yang, Jianshe;
Lv, Zhongwei

Publication type:

Article

Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3557, doi. 10.1007/s00259-022-05763-3

By:

Jonker, Pascal K. C.;
Metman, Madelon J. H.;
Sondorp, Luc H. J.;
Sywak, Mark S.;
Gill, Anthony J.;
Jansen, Liesbeth;
Links, Thera P.;
van Diest, Paul J.;
van Ginhoven, Tessa M.;
Löwik, Clemens W. G. M.;
Nguyen, Anh H.;
Coppes, Robert P.;
Robinson, Dominic J.;
van Dam, Gooitzen M.;
van Hemel, Bettien M.;
Fehrmann, Rudolf S. N.;
Kruijff, Schelto

Publication type:

Article

Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3412, doi. 10.1007/s00259-022-05806-9

By:

Trägårdh, Elin;
Enqvist, Olof;
Ulén, Johannes;
Hvittfeldt, Erland;
Garpered, Sabine;
Belal, Sarah Lindgren;
Bjartell, Anders;
Edenbrandt, Lars

Publication type:

Article

Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3419, doi. 10.1007/s00259-022-05801-0

By:

Signore, Alberto;
Lauri, Chiara;
Colandrea, Marzia;
Di Girolamo, Marco;
Chiodo, Erika;
Grana, Chiara Maria;
Campagna, Giuseppe;
Aceti, Antonio

Publication type:

Article

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3452, doi. 10.1007/s00259-022-05794-w

By:

de Koster, Elizabeth J.;
Vriens, Dennis;
van Aken, Maarten O.;
Dijkhorst-Oei, Lioe-Ting;
Oyen, Wim J. G.;
Peeters, Robin P.;
Schepers, Abbey;
de Geus-Oei, Lioe-Fee;
van den Hout, Wilbert B.

Publication type:

Article

Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3547, doi. 10.1007/s00259-022-05779-9

By:

Kim, Seok;
Bang, Ji-In;
Boo, Dachung;
Kim, Borham;
Choi, In Young;
Ko, SooJeong;
Yoo, Ie Ryung;
Kim, Kwangsoo;
Kim, Junmo;
Joo, YoungHwan;
Ryoo, Hyun Gee;
Paeng, Jin Chul;
Park, Jung Mi;
Jang, Woncheol;
Kim, Byungwon;
Chung, Yangha;
Yang, Dongyoon;
Yoo, Sooyoung;
Lee, Ho-Young

Publication type:

Article

Total-body [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3322, doi. 10.1007/s00259-022-05791-z

By:

Filippi, Luca;
Schillaci, Orazio

Publication type:

Article

The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3401, doi. 10.1007/s00259-022-05783-z

By:

Monaco, Lavinia;
De Bernardi, Elisabetta;
Bono, Francesca;
Cortinovis, Diego;
Crivellaro, Cinzia;
Elisei, Federica;
L'Imperio, Vincenzo;
Landoni, Claudio;
Mathoux, Gregory;
Musarra, Monica;
Pagni, Fabio;
Turolla, Elia Anna;
Messa, Cristina;
Guerra, Luca

Publication type:

Article

Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3581, doi. 10.1007/s00259-022-05778-w

By:

Lawal, Ismaheel O.;
Morgenstern, Alfred;
Vorster, Mariza;
Knoesen, Otto;
Mahapane, Johncy;
Hlongwa, Khanyisile N.;
Maserumule, Letjie C.;
Ndlovu, Honest;
Reed, Janet D.;
Popoola, Gbenga O.;
Mokoala, Kgomotso M. G.;
Mdlophane, Amanda;
Bruchertseifer, Frank;
Sathekge, Mike M.

Publication type:

Article

First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3373, doi. 10.1007/s00259-022-05781-1

By:

Kersting, David;
Sraieb, Miriam;
Seifert, Robert;
Costa, Pedro Fragoso;
Kazek, Sandra;
Kessler, Lukas;
Umutlu, Lale;
Fendler, Wolfgang Peter;
Jentzen, Walter;
Herrmann, Ken;
Büther, Florian;
Nader, Michael;
Rischpler, Christoph

Publication type:

Article

Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3492, doi. 10.1007/s00259-022-05770-4

By:

van der Weijden, Chris W. J.;
Meilof, Jan F.;
van der Hoorn, Anouk;
Zhu, Junqing;
Wu, Chunying;
Wang, Yanming;
Willemsen, Antoon T. M.;
Dierckx, Rudi A. J. O.;
Lammertsma, Adriaan A.;
de Vries, Erik F. J.

Publication type:

Article

First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3593, doi. 10.1007/s00259-022-05777-x

By:

Brouwers, Adrienne H.;
van Sluis, Joyce;
van Snick, Johannes H.;
Schröder, Carolina P.;
Baas, Inge O.;
Boellaard, Ronald;
Glaudemans, Andor W. J. M.;
Borra, Ronald J. H.;
Lammertsma, Adriaan A.;
Dierckx, Rudi A. J. O.;
Tsoumpas, Charalampos

Publication type:

Article

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3340, doi. 10.1007/s00259-022-05774-0

By:

Lam, Marnix;
Garin, Etienne;
Maccauro, Marco;
Kappadath, S. Cheenu;
Sze, Daniel Y.;
Turkmen, Cuneyt;
Cantasdemir, Murat;
Haste, Paul;
Herrmann, Ken;
Alsuhaibani, Hamad Saleh;
Dreher, Matthew;
Fowers, Kirk D.;
Salem, Riad

Publication type:

Article

Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3538, doi. 10.1007/s00259-022-05772-2

By:

Hu, Yan;
Liu, Guobing;
Yu, Haojun;
Gu, Jianying;
Shi, Hongcheng

Publication type:

Article

Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3529, doi. 10.1007/s00259-022-05771-3

By:

Clement, Dominique;
Navalkissoor, Shaunak;
Srirajaskanthan, Rajaventhan;
Courbon, Frédéric;
Dierickx, Lawrence;
Eccles, Amy;
Lewington, Valerie;
Mitjavila, Mercedes;
Percovich, Juan Carlos;
Lequoy, Benoît;
He, Beilei;
Folitar, Ilya;
Ramage, John

Publication type:

Article

Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3430, doi. 10.1007/s00259-022-05769-x

By:

Lauri, Chiara;
Signore, Alberto;
Glaudemans, Andor W. J. M.;
Treglia, Giorgio;
Gheysens, Olivier;
Slart, Riemer H. J. A.;
Iezzi, Roberto;
Prakken, Niek H. J.;
Debus, Eike Sebastian;
Honig, Susanne;
Lejay, Anne;
Chakfé, Nabil

Publication type:

Article

Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3320, doi. 10.1007/s00259-022-05768-y

By:

Sollini, Martina;
Hurle, Rodolfo;
Rodari, Marcello;
Chiti, Arturo;
Lazzeri, Massimo

Publication type:

Article

PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3387, doi. 10.1007/s00259-022-05765-1

By:

Fiz, Francesco;
Masci, Chiara;
Costa, Guido;
Sollini, Martina;
Chiti, Arturo;
Ieva, Francesca;
Torzilli, Guido;
Viganò, Luca

Publication type:

Article

Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3571, doi. 10.1007/s00259-022-05761-5

By:

Unterrainer, Lena M.;
Lindner, Simon;
Eismann, Lennert;
Casuscelli, Jozefina;
Gildehaus, Franz-Josef;
Bui, Vinh Ngoc;
Albert, Nathalie L.;
Holzgreve, Adrien;
Beyer, Leonie;
Todica, Andrei;
Brendel, Matthias;
Cyran, Clemens C.;
Karl, Alexander;
Stief, Christian G.;
Ledderose, Stephan T.;
Unterrainer, Marcus;
Bartenstein, Peter;
Wenter, Vera;
Kretschmer, Alexander

Publication type:

Article

EANM guideline on quality risk management for radiopharmaceuticals.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3353, doi. 10.1007/s00259-022-05738-4

By:

Gillings, Nic;
Hjelstuen, Olaug;
Behe, Martin;
Decristoforo, Clemens;
Elsinga, Philip H.;
Ferrari, Valentina;
Kiss, Oliver C.;
Kolenc, Petra;
Koziorowski, Jacek;
Laverman, Peter;
Mindt, Thomas L.;
Ocak, Meltem;
Patt, Marianne;
Todde, Sergio;
Walte, Almut

Publication type:

Article

Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3482, doi. 10.1007/s00259-021-05665-w

By:

Tang, Yongxiang;
Yu, Jie;
Zhou, Ming;
Li, Jian;
Long, Tingting;
Li, Yulai;
Feng, Li;
Chen, Dengming;
Yang, Zhiquan;
Huang, Yiyun;
Hu, Shuo

Publication type:

Article

[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3365, doi. 10.1007/s00259-021-05660-1

By:

Conen, Patrick;
Pennetta, Francesca;
Dendl, Katharina;
Hertel, Fabian;
Vogg, Andreas;
Haberkorn, Uwe;
Giesel, Frederik L.;
Mottaghy, Felix M.

Publication type:

Article

Works matching IS 1619-7070 AND VI 49 AND IP 10 AND DT 2022

To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment.

Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients.

Letter to the editor.

EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([<sup>177</sup>Lu]Lu-PSMA).

[<sup>177</sup>Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database.

Response to letter to the editor.

2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe.

Hossein Jadvar and Patrick M. Colletti (Eds): Nuclear Medicine: the Essentials: Lippincott Williams & Wilkins (LWW) 2021. ISBN: 978–1-49–630,064-5.

Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals.

225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma.

The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer.

Quantification of amyloid PET for future clinical use: a state-of-the-art review.

Construction and implementation of regional high-level PET alliance based on international consensus.

Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection.

Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians.

Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [<sup>18</sup>F]FDG PET/CT study.

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.

Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics.

Total-body [<sup>18</sup>F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true?

The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.

Hematologic toxicity profile and efficacy of [<sup>225</sup>Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer.

First experiences with dynamic renal [<sup>68</sup>Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate.

Quantitative assessment of myelin density using [<sup>11</sup>C]MeDAS PET in patients with multiple sclerosis: a first-in-human study.

First-time imaging of [<sup>89</sup>Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner.

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study.

Diagnostic performance of total-body <sup>18</sup>F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT.

Efficacy and safety of <sup>177</sup>Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.

Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.

Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging.

PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.

Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.

EANM guideline on quality risk management for radiopharmaceuticals.

Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with <sup>18</sup>F-SynVesT-1 positron emission tomography imaging.

[<sup>68</sup> Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease.